By Marie Rosenthal, MS
The FDA issued an emergency use authorization (EUA) for casirivimab and imdevimab (Regeneron)—the same cocktail given to Donald Trump when he was hospitalized for COVID-19.
Casirivimab and imdevimab should be administered together for the treatment of mild to moderate COVID-19 in adults and children (≥12 years of age weighing ≥40 kg) with a positive COVID-19 test result and who are at high risk for progressing to severe COVID-19, but who are not hospitalized.